Shi Lin-Jun, Wang Yong, Yang Chi, Jiang Wei-Wen
Department of Oral Mucosal Diseases, Shanghai Ninth People's Hospital, Shanghai Key Laboratory of Stomatology, Shanghai Research Institute of Stomatology, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
J Oral Maxillofac Surg. 2012 Nov;70(11):e586-91. doi: 10.1016/j.joms.2012.07.024. Epub 2012 Aug 22.
Artificial grafts have been investigated for use in the repair of oral mucosal defects. The aim of this retrospective study was to present the outcomes of the use of acellular dermal matrix (ADM) grafts to repair oral mucosal defects.
Data from 36 patients with oral mucosal defects reconstructed with ADM grafts from 2003 through 2009 were reviewed. All patients were followed-up for at least 6 months to observe the graft repair, wound-healing time, contracture, color, infection, pain, immunologic reaction, texture of the graft, and clinical course. Graft success was defined as the ADM graft being replaced by new mucosa-like tissue and the oral mucosal defect being covered with the new mucosa-like tissue. Any evidence of incomplete graft re-epithelialization or graft sloughing was considered a graft failure (complete or incomplete).
Of the 36 cases, 34 grafts (94.4%) were successfully replaced with new mucosa-like tissues and only 2 grafts (5.6%) failed. No complaints such as pain, immunologic reaction, or infection were observed during the follow-up. Mild graft contraction occurred in 7 patients with lip or buccal defects, especially at approximately 3 to 5 weeks after the reconstructive surgery.
The ADM grafts for oral mucosal defects were safe and effective. The present data support the clinical application of ADM grafts in reconstructing oral mucosal defects caused by various oral diseases.
已对人工移植物用于修复口腔黏膜缺损进行了研究。本回顾性研究的目的是呈现使用脱细胞真皮基质(ADM)移植物修复口腔黏膜缺损的结果。
回顾了2003年至2009年期间36例用ADM移植物重建口腔黏膜缺损患者的数据。所有患者均接受至少6个月的随访,以观察移植物修复情况、伤口愈合时间、挛缩、颜色、感染、疼痛、免疫反应、移植物质地及临床病程。移植物成功定义为ADM移植物被新的黏膜样组织替代且口腔黏膜缺损被新的黏膜样组织覆盖。任何移植物再上皮化不完全或移植物脱落的证据均被视为移植物失败(完全或不完全)。
36例中,34例移植物(94.4%)成功被新的黏膜样组织替代,仅2例移植物(5.6%)失败。随访期间未观察到疼痛、免疫反应或感染等主诉。7例唇部或颊部缺损患者出现轻度移植物挛缩,尤其在重建手术后约3至5周。
用于口腔黏膜缺损的ADM移植物安全有效。本数据支持ADM移植物在重建由各种口腔疾病引起的口腔黏膜缺损中的临床应用。